Introduction
============

Oral anticoagulants (OAs) are commonly used in patients with artificial heart valves, deep vein thrombosis, and pulmonary embolisms to prevent thromboembolic events ([@B35]; [@B5]; [@B2]). Most of these drugs act as vitamin K antagonists, and their mechanism of action is through inhibition of vitamin K dependent clotting factors (II, VII, IX, X) ([@B37]; [@B5]). In recent years, new oral anticoagulants (NOACs) have emerged and been used in clinical practice ([@B42]). Because of the aging populations and high rates of cardiovascular disease in most countries, a large number of patients will be undergoing oral anticoagulant treatment ([@B38]; [@B43]). However, although oral anticoagulant treatment (OAT) with vitamin K antagonists is effective for prophylaxis of potentially life-threatening thromboembolic events, the risk of post-operative bleeding has been a concern in the medical treatment of patients undergoing OAT compared with non-anticoagulated subjects ([@B46]; [@B47]; [@B44]).

According to previous reports ([@B15]; [@B33]), minor dental surgery, which is the common procedure in dental health care and routine outpatient treatment, including tooth extractions, dental implant surgery, mucoperiosteal flaps, periodontal surgical procedures, alveoloplasties, limited oral soft tissue surgery, and augmentation procedures (e.g., elevation of the maxillary sinus). Because most of these dental operations can be invasive and hemorrhagic, concern over the safety and efficacy of the OAT and the accompanying bleeding risks related to these invasive dental procedures is unavoidable ([@B45]; [@B36]; [@B32]). However, clinical studies evaluating this risk have reported conflicting results. The results of some studies have revealed that the post-operative bleeding rate in patients undergoing OAT was not higher than that in patients not undergoing OAT ([@B7], [@B6]; [@B10]). Moreover, using local hemostasis methods, minor dental surgery can be performed safely in anticoagulated outpatients, without any modification of their ongoing anticoagulant therapy. On the contrary, some studies have reported more post-operative bleeding in OAT patients ([@B19]; [@B31]), and OAT may increase the risk of bleeding after these invasive procedures ([@B30]).

Furthermore, some systemic reviews have discussed these clinical problems, but the conclusions of these reviews were also inconsistent. Two systemic reviews concluded that OAT patients who continue the OA medication do not have a significantly higher risk of post-operative bleeding than non-OAT patients ([@B38]; [@B33]), while [@B36] thought that the OAT patients are at a higher risk for enhanced bleeding tendency compared to the non-OAT patients, when the anticoagulant therapy is continued ([@B36]). Moreover, these systemic reviews did not conduct a quantitative analysis to validate their conclusions ([@B38]; [@B36]; [@B33]). These conclusions of clinical studies and systematic reviews indicate that whether the post-operative bleeding rate is higher in OAT patients than in the non-OAT patients is need further research.

Because of the special anatomical site of an oral cavity, severe post-surgical bleeding could lead to serious consequences, including life-threatening upper airway obstruction, dysphagia, or post-operative trismus ([@B21]; [@B49]; [@B48]; [@B36]). If such events occur, OAT patients would be more at risk than healthy patients, which could discourage OAT patients from seeking future dental treatment ([@B41]). In addition, as patients increasingly tend to maintain their dental health as they get older, dentoalveolar surgery is more often indicated for elderly patients who are taking OAs ([@B12]). Therefore, it is of great importance to evaluate the post-operative bleeding risks of OAT patients after minor dental surgery and to take effective hemostatic measures.

Considering that a single study may lack the power to provide reliable conclusion due to the small number of subjects, and lack of quantitative analysis in the available systemic reviews, a meta-analysis is required to quantitatively assess the risk. Therefore, we conducted this meta-analysis by collecting available evidences, which comparing the post-operative (i.e., minor dental surgery) bleeding rates of OAT patients without interruptions or modifications to their therapy with those of non-OAT patients, to evaluate the post-operative bleeding risk of OAT. These results will provide clinicians with better evidence-based evaluations and recommendations.

Materials and Methods {#s1}
=====================

Search Strategy and Selection Criteria
--------------------------------------

In this meta-analysis, we included clinical studies that compared the post-operative bleeding rates (following minor dental surgery) of OAT patients without interrupted or altered therapy and non-OAT patients. Studies with available data that could be extracted were also included. The post-operative bleeding events include: slight bleeding and moderate bleeding, and severe hemorrhaging. The exclusion criteria were (1) animal studies or *in vitro* studies, (2) reviews, case reports or comments, (3) studies without available data that could be extracted, and (4) studies with patients who were also being treated with antiplatelet drugs or undergoing major surgery.

We searched PubMed, Embase for related studies published from January 1985 to December 2016, and the language was restricted to English. Then, we searched the Cochrane Library, without restrictions. The combination of the following keywords was used: "oral anticoagulant," "oral anticoagulation treatment (OAT)," "bleeding," and "dental surgery." Additional studies were identified by manual searches of the reference lists of the related articles and reviews. These results were independently assessed by two reviewers (SQ and XJ), and any disagreement was resolved through discussion with a third reviewer (LHC).

Briefly, based on the inclusion criteria, the studies were selected as follows. First, after eliminating duplicate articles, irrelevant records were excluded by reading the titles and abstracts. Then, full-texts of the potential studies were scanned, and only the studies meeting the inclusion criteria were ultimately included in our meta-analysis.

Data Extraction and Quality Assessment
--------------------------------------

The following information was extracted from each included study: the study ID (first author and year of publication), study design, type of dental surgery, characteristics of the subjects (including the number of patients in each group, age range, sex, oral anticoagulant therapy in the OAT group, and number of patients with post-operative bleeding), hemostasis protocol, and follow-up time, as well as a brief conclusion from study. This process was independently performed by two reviewers (SQ and XJ).

The quality assessment was completed by two reviewers (ZT and ZB) using the Newcastle-Ottawa Scale (NOS). In this assessment tool, the study selection, comparability, and outcomes are used to appraise the methodological quality of the included studies, with a maximum of nine points for each study ([@B53]). NOS scores of 1--3, 4--6, and 7--9 indicated low, moderate, and high study quality, respectively.

Data Synthesis and Analysis
---------------------------

Comprehensive Meta-Analysis software package (Version 2.0; Biostat) was used to perform the meta-analysis. The relative risk (RR) and 95% confidence interval (CI) were pooled to estimate the risk of post-operative bleeding in the OAT patients compared with the non-OAT patients. Heterogeneity between studies was tested using I^2^ statistics (I^2^ values of 25, 50, and 75% were considered low, moderate, and high, respectively). A fixed effects model was used if the heterogeneity was low; otherwise, a random effects model was used. Sensitivity analysis and cumulative analysis was performed to analysis the stability of the pooled results. Subgroup analyses of the different dental surgeries and different oral anticoagulants were also performed.

Results
=======

Study Selection
---------------

Initially, 613 papers were identified through our search strategy. We reviewed 32 papers in full-text, 14 of which did not have a non-OAT group or a continued OAT group ([@B4]; [@B30], [@B29]; [@B51]; [@B40]; [@B8]; [@B27]; [@B28]; [@B20]; [@B52]; [@B1]; [@B9]; [@B18]; [@B55]); two studies aimed to evaluate the local hemostatic effect of drugs ([@B3]; [@B13]); one study included the patients with antiplatelet therapy, and data was collected by tooth instead by patient ([@B31]); two were meeting abstracts and the data overlapped with other studies ([@B11]; [@B22]); and in the last study, the OAT patients skipped the OA before the dental surgery ([@B39]). Eventually, 12 studies ([@B14]; [@B54]; [@B7], [@B6]; [@B34]; [@B19]; [@B12]; [@B10]; [@B16]; [@B23]; [@B25],[@B26]) were included in our meta-analysis. A flow diagram of the study selection process is shown in **Figure [1](#F1){ref-type="fig"}**.

![**A flowchart of the retrieved studies**. OAT, oral anticoagulation treatment.](fphar-08-00058-g001){#F1}

Summary of the Included Studies
-------------------------------

The publication dates of the 12 included studies ranged from 2000 to 2016. Ten studies ([@B14]; [@B54]; [@B7], [@B6]; [@B34]; [@B12]; [@B10]; [@B16]; [@B25],[@B26]) are prospective studies and two are retrospective studies ([@B19]; [@B23]). Four studies ([@B6]; [@B16]; [@B25],[@B26]) researched dental implants in OAT patients, and four studies ([@B54]; [@B7]; [@B34]; [@B23]) focused on dental extractions. In the last four studies ([@B14]; [@B19]; [@B12]; [@B10]) the surgeries included dental extraction, apicoectomy, dental implant surgery, limited intraoral soft tissue surgery, and so on. All OAT patients maintained their anticoagulation medication therapies. The value of the international normalized ratio (INR) in the included studies was less than 4.2 (**Table [1](#T1){ref-type="table"}**). To stop the intraoperative and post-operative bleeding, all studies adopted local hemostatic measures. These measures and main conclusions of the included studies can be found in the Supplementary Table [A1](#SM1){ref-type="supplementary-material"}.

###### 

Summary of the included studies.

  Study ID               Study design    Dental surgery                                             Oral anticoagulant therapy                                                                                         Follow up time      NOS score
  ---------------------- --------------- ---------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------ ------------------- -----------
  Febbo A 2016           Retrospective   Dental extraction                                          Patients were treated with vitamin warfarin and INR less than 4                                                    Day 1 to day 10     7
  Gómez-Moreno G 2016b   Prospective     Dental implant surgery                                     Patients had been taking dabigatran for over 6 months (150 mg orally every 12 h).                                  Days 3, 8           8
  Gómez-Moreno G 2016a   Prospective     Dental implant surgery                                     Patients had been treated with rivaroxaban for over 6 month                                                        Days 3, 8           8
  Clemm R 2016           Prospective     Dental implant surgery                                     Patients were treated with vitamin K inhibitors or direct oral anticoagulants.                                     Day 10              7
  Bajkin BV 2015         Prospective     Dental extraction, apicectomy, etc.                        Patients were treated with vitamin K antagonists and INR: 2.0--4.2                                                 Days 1, 2, 5, 7     7
  Broekema FI 2014       Prospective     Dental extraction, apicectomy, dental implant surgery      Patients were treated with vitamin K antagonists and INR: 1.8--3.5.                                                1 week              7
  Eichhorn W 2012        Retrospective   Osteotomies, apicoectomies, extractions, etc.              Patients were treated with coumarins, INR : 1.2- 4.2                                                               Days 1, 7, 10, 14   5
  Karslı ED 2011         Prospective     Dental extraction                                          Patients on warfarin treatment without interruption, INR \< 4.0                                                    48 h                6
  Bacci C 2011           Prospective     Dental implant surgery                                     INR: 1.8--2.98; warfarin therapy \>6 months; normal hemoglobin value and platelet count                            Days 3, 8           8
  Bacci C 2010           Prospective     Dental extraction                                          Patients were treated with warfarin for at least 3 months, and the therapy was maintained unchanged. INR: 1.8--4   Days 3, 8           8
  Zanon E 2003           Prospective     Dental extraction                                          Patients on warfarin without changed. INR: 1.8--4                                                                  Days 3, 8           7
  Campbell JH 2000       Prospective     Extraction, alveoloplasty, intraoral soft tissue surgery   Patients continued their anticoagulant regimens. INR:1.2--2.9                                                      Day 1               5

INR, international normalized ratio

.

The quality assessment results are shown in **Table [1](#T1){ref-type="table"}**, using the NOS. Nine studies ([@B54]; [@B7], [@B6]; [@B12]; [@B10]; [@B16]; [@B23]; [@B25],[@B26]) scored more than seven points and were considered to be of high quality. Three studies ([@B14]; [@B34]; [@B19]) scored less than six points and were considered to be of moderate quality. No studies were found with low quality.

From these included studies, a total of 2271 non-OAT patients and 2102 OAT patients were studied. Twenty-five of the non-OAT patients presented with post-operative bleeding, and the total bleeding rate was 1.10%. In the OAT group, 91 patients presented with post-operative bleeding, and the total bleeding rate was 4.33%, which was higher than that in the non-OAT group (**Table [2](#T2){ref-type="table"}**). Totally, two OAT patients in two studies developed a severe bleeding and needed to be hospitalized (Supplementary Table [A1](#SM1){ref-type="supplementary-material"}).

###### 

Patient characteristics and post-operative bleeding rates in the included studies.

  Study ID               OAT group       Non-OAT group                                                                                  
  ---------------------- --------------- ---------------------- -------- ----------- --------------- ----------------------- ---------- -----------
  Febbo A 2016           439 (278/161)   69.53^a^               9        2.05%       439 (234/205)   65.19 ^a^               0          0%
  Gómez-Moreno G 2016b   29 (19/10)      49--71 (66.7 ± 9.15)   2        6.90%       42              NR                      2          4.76%
  Gómez-Moreno G 2016a   18 (12/6)       46--73 (64.4 ± 7.84)   1        5.56%       39              NR                      2          5.13%
  Clemm R 2016           46^b^           NR                     2        4.35%       447             NR                      3          0.67%
  Bajkin BV 2015         125 (81/44)     65.6 ± 9.83            7        5.60%       85 (52/33)      64.5 ± 9.8              1          1.18%
  Broekema FI 2014       32^b^           NR                     3        9.38%       103 (68/35)     21--85                  2          1.94%
  Eichhorn W 2012        637 (423/214)   26--93 (68 ± 12.1)     47       7.38%       285 (138/147)   23--88 (64 ± 10.3)      2          0.70%
  Karslı ED 2011         13 (7/6)        32--69 (46.2 ± 11)     6^c^     46.15%      13 (7/6)        29--61 (40.38 ± 9.23)   3**^c^**   23.08%
  Bacci C 2011           52^d^ (39/13)   41--77 (56.2 ± 8.88)   2        3.85%       109             NR                      3          2.75%
  Bacci C 2010           451 (246/205)   38--89 63.5^a^         7        1.55%       449 (202/247)   35--92 66.4^a^          4          0.89%
  Zanon E 2003           250 (59/191)    44--88                 4        1.60%       250 (84/166)    42--92                  3          1.20%
  Campbell JH 2000       12              NR                     1        8.33%       10              NR                      0          0%
  **Total**              **2102**                               **91**   **4.33%**   **2271**                                **25**     **1.10%**

a

Mean age of the patients;

b

data from the OAT group were a subgroup in the original research;

c

in this study, the patients who used extra gauze swabs during the first 48 h for bleeding control were counted;

d

two patients were excluded in the final analysis. NR, not reported

.

Meta-analysis
-------------

### Primary Outcomes

A meta-analysis of the post-operative bleeding rate in the OAT and non-OAT groups was performed. The pooled RR and 95% CI for the OAT patients versus non-OAT patients was 2.794 (95% CI: 1.722--4.532), and this difference was statistically significant (*P* = 0.000, **Figure [2](#F2){ref-type="fig"}**). The I^2^ value was 0, therefore, heterogeneity between the included studies was low, and a fixed effects model was selected. The sensitivity analysis performed by sequentially removing individual studies revealed stable and statistically significant results (**Figure [3](#F3){ref-type="fig"}**). Furthermore, a cumulative analysis performed by the order of publication date showed that with overlay of numbers of studies and patients, the results tend to be stable (**Figure [4](#F4){ref-type="fig"}**)

![**Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g002){#F2}

![**Forest plot of the sensitivity analysis performed by sequential removing single studies**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g003){#F3}

![**Forest plot of the cumulative meta-analysis by publication year**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g004){#F4}

### Secondary Outcomes

**Figures [5](#F5){ref-type="fig"}**--**[7](#F7){ref-type="fig"}** show the subgroup analysis results of the different minor dental surgeries. For dental implant surgery and dental extraction, the pooled RRs were 2.136 (95% CI: 0.825--5.531, fixed effect model, I^2^ = 0, **Figure [6](#F6){ref-type="fig"}**) and 2.003 (95% CI: 0.987--4.063, fixed effect model, I^2^ = 0, **Figure [5](#F5){ref-type="fig"}**), respectively. The results indicated no significant difference between the dental implant surgery and dental extraction subgroups (*P* = 0.118 and *P* = 0.054, respectively). The final studies were composed of mixed dental surgeries, and the pooled RR was 6.361 (95% CI: 2.522--16.040, fixed effect model, I^2^ = 0), which indicated a significant difference (*P* = 0.000, **Figure [7](#F7){ref-type="fig"}**).

![**Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the dental extraction subgroup**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g005){#F5}

![**Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the dental implant subgroup**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g006){#F6}

![**Forest plot of the post-operative bleeding risk comparison between OAT patients and non-OAT patients in the mixed surgery subgroup**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g007){#F7}

The OAT patients in nine studies ([@B14]; [@B54]; [@B7], [@B6]; [@B34]; [@B19]; [@B12]; [@B10]; [@B23]) were being treated with vitamin K antagonists, and two studies focused on rivaroxaban ([@B25]) and dabigatran ([@B26]), which belong to the NOACs group. Both of these two types of anticoagulants were extracted from the ([@B16]) study through our meta-analysis. In the NOACs subgroup, the pooled RR was 1.603 (95% CI: 0.430--5.980), which failed to show that treatment with NOACs increased the post-operative bleeding rate compared with non-OAT patients (*P* = 0.482, I^2^ = 0, fixed effects model, **Figure [8](#F8){ref-type="fig"}**). In the subgroup of vitamin K antagonists, the pooled RR was 3.067 (95% CI: 1.838--5.118), which was a significant difference (*P* = 0.000, I^2^ = 0, fixed effect model). These results are shown in **Figure [9](#F9){ref-type="fig"}**.

![**Forest plot of the post-operative bleeding risk comparison between patients treated with vitamin K antagonists and non-OAT patients**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g008){#F8}

![**Forest plot of the post-operative bleeding risk comparison between patients treated with NOACs and non-OAT patients**. RR, relative risk; CI, confidence interval.](fphar-08-00058-g009){#F9}

Discussion
==========

The question about discontinued, reducing or maintaining before minor dental surgeries has been a controversial subject. A definitive, standardized protocol for managing minor dental surgery in anticoagulated patients is still lacking ([@B7]). It was suggested that OAT patients (INR 2--4) who continued their anticoagulants do not have a significantly higher risk of post-operative bleeding than non-OAT patients ([@B38]). However, some reviews concluded that more minor bleedings might occur in OAT patients and that the use of local hemostatic measures, as well as close and extended post-operative monitoring, is vital ([@B24]; [@B33]). Nevertheless, these reviews only had carried on the qualitative description without quantitative analysis. Therefore, it is still disputed whether OAT would increase the post-operative bleeding risk following minor dental surgery, an invasive and hemorrhagic procedure. Our meta-analysis focused on this question, and we performed a quantitative analysis to evaluate the risk by comparing the post-operative bleeding rates of OAT patients without interrupted or altered anticoagulant use and non-OAT patients.

Based on our search strategy and selection criteria, 12 studies ([@B14]; [@B54]; [@B7], [@B6]; [@B34]; [@B19]; [@B12]; [@B10]; [@B16]; [@B25],[@B26]) were included in our meta-analysis. The post-operative bleeding rate in the OAT group (4.32%) was higher than that in the non-OAT group (1.10%). The pooled RR for the OAT patients versus the non-OAT patients was 2.794 (95% CI: 1.722--4.532), and the difference was statistically significant, which indicates that OAT will increase the risk of post-operative bleeding following minor dental surgery. Furthermore, sensitivity analysis performed by sequentially removing individual studies did not change the results. To stop the bleeding, all included studies used local hemostatic methods after the dental surgeries, while only two OAT patients in two studies developed a severe bleeding and needed to be hospitalized ([@B16]; [@B23]). Evidence from the current analysis suggested that following minor dental surgery, patients who were treated with oral anticoagulants might have a higher post-operative bleeding risk compared with non-OAT patients, which differs from the previous systematic review ([@B38]). Fortunately, using careful local hemostatic methods, the bleeding can be stopped effectively.

As previously mentioned, the value of heterogeneity between studies was tested using I^2^ statistics. A fixed effects model was used if the heterogeneity was low; otherwise, a random effects model was used. We know that when the heterogeneity is low, a fixed model will give us a more reliable result. While when the heterogeneity was high, subgroup analysis will be made to explore the source of heterogeneity. Despite the overall heterogeneity was low in this study, we had still made the subgroup analysis. Here are the reasons: first, minor dental surgery is not a single operation and it includes several types of surgeries; OAs are also composed of several kinds of drugs. The most common OAs, vitamin K antagonists and NOACs, have different mechanism of action. Therefore, we want to identify the association between the bleeding rate and different dental surgeries or anticoagulants to give more guidance for clinicians.

Because the category of minor dental surgery includes several types of surgeries, we performed a subgroup analysis to evaluate the post-operative bleeding risk in the different minor dental surgeries in the included studies. Dental implants are generally considered effective and reliable restorations to replace lost teeth and to restore masticatory function ([@B50]), and they have been increasingly accepted by patients. Four studies ([@B6]; [@B16]; [@B25],[@B26]) focused on dental implant surgery, and the subgroup meta-analysis revealed that the pooled RR was 2.136 (95% CI: 0.825--5.531), with no significant difference (*P* = 0.17). Four studies ([@B54]; [@B7]; [@B34]; [@B16]) focused on dental extractions, one of the most common dental surgeries, and the results of the subgroup meta-analysis (pooled RR: 2.003, 95% CI: 0.987--3.063, *P* = 0.054) was similar to the dental implant subgroup meta-analysis. The results might indicate that with strong local hemostatic measures, the post-operative bleeding risk of OAT patients is not higher than that of non-OAT patients. The operations in the other four studies ([@B14]; [@B19]; [@B12]; [@B10]) were mixed (i.e., several dental surgeries). However, the results reveal that the pooled RR was 6.361 (95% CI: 2.522--16.040, *P* = 0.000), indicating that the bleeding risk of the OAT patients was high. Considering the heterogeneity of the surgeries in these three studies, more studies that focus on single surgeries will be needed in the future. Despite the level of evidence about what extent a safe and successful dental treatment in OAT patients is feasible was lacking ([@B36]), however, the intraoperative operation must be as atraumatic as possible to reduce post-operative bleeding.

Vitamin K antagonists (e.g., warfarin) are commonly used in patients with artificial heart valves, deep vein thrombosis, etc. ([@B35]; [@B5]; [@B17]). According to the guidelines developed at the Academic Centre for Dentistry Amsterdam (ACTA), the INR of the patients taking vitamin K antagonists (which is measured within 24--72 h preoperatively) must be ≤3.5 ([@B12]). While other studies have reported that an INR \< 4 was a safe range prior to dental surgery ([@B21]; [@B6]; [@B34]; [@B32]). The INR value was less than 4.2 in nine of the included studies in which the OAT patients were being treated with vitamin K antagonists. The pooled RR in the vitamin K antagonists subgroup analysis was 3.067 (95% CI: 1.838--5.118, *P* = 0.000), indicating that under the current range, the bleeding rate of the patients treated with vitamin K antagonists was higher than that of the non-OAT patients. However, in the subgroup of NOACs, the pooled RR was 1.603 (95% CI: 0.430--5.980, *P* = 0.482). Based on the two opposite pooled analysis results above, we may conclude that The NOACs might be safer than the vitamin K antagonists in minor dental surgery. Furthermore, the patients treated with NOACs in these three studies underwent dental implant surgery, hence the results of the subgroup analysis indicated that the NOACs might be safer than the vitamin K antagonists for dental implant surgery. Our conclusion was similar to that of [@B25], who reported that implant insertion surgery has been made safer and easier, and does not require special monitoring for patients being treated with these new anticoagulants ([@B25]). However, considering the limited number of studies in the subgroup of NOACs and the lacking of direct evidence that compared the vitamin K antagonists and NOACs, more studies are required in the future.

To our knowledge, this is the first meta-analysis to estimate the association between OAT and post-operative bleeding following minor dental surgery by quantitative analysis, especially grouped by different dental surgeries and different oral anticoagulants. Not only did we research electronic databases to identify potential interests, but also we manually examined reference lists from relevant studies. The NOS assessment tool was used to evaluate each of the included studies and none of them had low quality. In the meta-analysis and subgroup analyses, the included studies had low heterogeneity, which significantly increased the statistical power of our analysis. Moreover, sensitivity and cumulative analyses were performed to determine the stability of the pooled results. However, our meta-analysis has three limitations. First, although the included studies had low heterogeneity, the types of surgery and the oral anticoagulants used differed. Second, the search was limited to English-language studies, which might have introduced selection bias to this meta-analysis. Third, because of limit information provided by the included studies, we did not explore the bleeding risk of OAT patients by controlling for factor affecting bleeding risk such as INR value.

In summary, the following conclusions were made: (1) The OAT patients had a higher post-operative bleeding risk than the non-OAT patients following minor dental surgery, and the local hemostatic methods effectively stopped the bleeding; (2) For the dental implant surgeries and dental extractions, our study failed to demonstrate a higher risk of bleeding in the OAT patients compared with the non-OAT patients; (3) The NOACs might be safer than the vitamin K antagonists in dental implant surgery. The present meta-analysis will give clinical doctors a better understanding of the risks of post-operative bleeding in OAT patients after minor dental surgery and help patients make rational decisions. Besides, more well-designed studies with adequate controls for confounding factors are required for future research.
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